Acalabrutinib FDA approval - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of an AI semiconductor chip and data center infrastructure as Marvell Technology’s S&P 500 entry puts MRVL stock, AI chip valuations, and index-fund demand in sharper investor focus.

Is Marvell Technology’s S&P 500 inclusion a reward for AI growth or a valuation warning?

Representative image of a modern urban hotel in Ahmedabad, where Royal Orchid Hotels’ Z by Regenta expansion highlights ROHLTD’s push into Gujarat’s lifestyle hospitality market.

Is Royal Orchid Hotels using Ahmedabad to prove its lifestyle hotel play can scale faster?

Representative image of a premium hill resort in Mussoorie for Leisure Hotels Group Samsara Hill Resort story.

Can Samsara Hill Resort help Leisure Hotels Group turn Mussoorie pressure into premium pricing power?

Representative image of underground HVDC cable construction and wind power infrastructure, highlighting how Germany’s A-Nord project aims to connect northern renewable energy with western industrial demand centres.

A-Nord HVDC project: Why Germany’s 2GW wind power corridor matters in 2026

Read More

Pharma Industry News

FDA grants accelerated approval to AstraZeneca’s Calquence for mantle cell lymphoma treatment

AstraZeneca has achieved a significant milestone with the early FDA approval of Calquence (acalabrutinib) for the treatment of…

bypharmanewsdaily

November 1, 2017

web analytics